Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) has been given an average recommendation of “Hold” by the five brokerages that are covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price objective among […]
Platinum Investment Management Ltd. reduced its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) by 42.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 343,955 shares of the company’s stock after selling 254,657 shares during the quarter. Platinum Investment Management Ltd. owned […]
Wave Life Sciences (NASDAQ:WVE – Get Rating) had its price target cut by Mizuho from $13.00 to $10.00 in a report issued on Wednesday morning, The Fly reports. Several other equities analysts have also issued reports on the company. Jefferies Financial Group lowered Wave Life Sciences from a buy rating to a hold rating and […]
Jefferies Financial Group downgraded shares of Wave Life Sciences (NASDAQ:WVE – Get Rating) from a buy rating to a hold rating in a research note published on Tuesday, The Fly reports. The brokerage currently has $5.00 price objective on the stock, down from their prior price objective of $7.00. Several other research firms have also […]
M28 Capital Management LP reduced its stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) by 26.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,903,405 shares of the company’s stock after selling 2,078,799 shares during the period. Wave […]